A detailed history of New Republic Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, New Republic Capital, LLC holds 1,100 shares of AMGN stock, worth $318,890. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,100
Previous 1,077 2.14%
Holding current value
$318,890
Previous $337 Million 5.33%
% of portfolio
0.2%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$309.38 - $337.38 $7,115 - $7,759
23 Added 2.14%
1,100 $354 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $8,145 - $9,898
31 Added 2.96%
1,077 $337 Million
Q1 2024

May 07, 2024

SELL
$268.87 - $324.56 $25,811 - $31,157
-96 Reduced 8.41%
1,046 $297 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $49,094 - $55,384
192 Added 20.21%
1,142 $329 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $207,717 - $257,886
950 New
950 $255 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track New Republic Capital, LLC Portfolio

Follow New Republic Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Republic Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Republic Capital, LLC with notifications on news.